Ignite Creation Date:
2025-12-25 @ 1:47 AM
Ignite Modification Date:
2026-03-06 @ 10:31 AM
Study NCT ID:
NCT04027894
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-01-27
First Post:
2019-07-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study to Evaluate Safety and Efficacy of Rifamycin SV MMX in Treating Traveler's Diarrhea in Children Age 12 to 17 Years
Sponsor:
RedHill Biopharma Limited
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2025-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-12
Completion Date Type:
ESTIMATED
First Submit Date:
2019-07-12
First Submit QC Date:
None
Study First Post Date:
2019-07-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-01-26
Last Update Post Date:
2023-01-27
Last Update Post Date Type:
ACTUAL